BG64974B1 - Фармацевтична форма, съдържаща моксифлоксацин - Google Patents

Фармацевтична форма, съдържаща моксифлоксацин Download PDF

Info

Publication number
BG64974B1
BG64974B1 BG105459A BG10545901A BG64974B1 BG 64974 B1 BG64974 B1 BG 64974B1 BG 105459 A BG105459 A BG 105459A BG 10545901 A BG10545901 A BG 10545901A BG 64974 B1 BG64974 B1 BG 64974B1
Authority
BG
Bulgaria
Prior art keywords
administration
moxifloxacin
pharmaceutical
use according
oral use
Prior art date
Application number
BG105459A
Other languages
Bulgarian (bg)
English (en)
Other versions
BG105459A (en
Inventor
Patrick Bosche
Hans Mahler
Claus Weisemann
Original Assignee
Bayer Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7889824&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BG64974(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Aktiengesellschaft filed Critical Bayer Aktiengesellschaft
Publication of BG105459A publication Critical patent/BG105459A/xx
Publication of BG64974B1 publication Critical patent/BG64974B1/bg

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
BG105459A 1998-11-10 2001-04-20 Фармацевтична форма, съдържаща моксифлоксацин BG64974B1 (bg)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19855758 1998-11-10

Publications (2)

Publication Number Publication Date
BG105459A BG105459A (en) 2001-12-29
BG64974B1 true BG64974B1 (bg) 2006-11-30

Family

ID=7889824

Family Applications (1)

Application Number Title Priority Date Filing Date
BG105459A BG64974B1 (bg) 1998-11-10 2001-04-20 Фармацевтична форма, съдържаща моксифлоксацин

Country Status (41)

Country Link
US (1) US6610327B1 (cg-RX-API-DMAC7.html)
EP (1) EP1128831B1 (cg-RX-API-DMAC7.html)
JP (1) JP4809978B2 (cg-RX-API-DMAC7.html)
KR (1) KR100650489B1 (cg-RX-API-DMAC7.html)
CN (1) CN1149993C (cg-RX-API-DMAC7.html)
AR (1) AR021074A1 (cg-RX-API-DMAC7.html)
AT (1) ATE279193T1 (cg-RX-API-DMAC7.html)
AU (1) AU745282B2 (cg-RX-API-DMAC7.html)
BG (1) BG64974B1 (cg-RX-API-DMAC7.html)
BR (2) BRPI9915208B8 (cg-RX-API-DMAC7.html)
CA (1) CA2349161C (cg-RX-API-DMAC7.html)
CO (1) CO5070571A1 (cg-RX-API-DMAC7.html)
CU (1) CU23260B7 (cg-RX-API-DMAC7.html)
CZ (1) CZ292069B6 (cg-RX-API-DMAC7.html)
DE (1) DE59910858D1 (cg-RX-API-DMAC7.html)
DK (1) DK1128831T3 (cg-RX-API-DMAC7.html)
EE (1) EE04418B1 (cg-RX-API-DMAC7.html)
ES (1) ES2229786T3 (cg-RX-API-DMAC7.html)
HK (1) HK1042245B (cg-RX-API-DMAC7.html)
HN (1) HN1999000183A (cg-RX-API-DMAC7.html)
HR (1) HRP20010332B1 (cg-RX-API-DMAC7.html)
HU (1) HU229065B1 (cg-RX-API-DMAC7.html)
ID (1) ID29089A (cg-RX-API-DMAC7.html)
IL (2) IL142642A0 (cg-RX-API-DMAC7.html)
MA (1) MA26757A1 (cg-RX-API-DMAC7.html)
MY (1) MY121114A (cg-RX-API-DMAC7.html)
NO (1) NO319342B1 (cg-RX-API-DMAC7.html)
NZ (1) NZ511554A (cg-RX-API-DMAC7.html)
PE (1) PE20001304A1 (cg-RX-API-DMAC7.html)
PL (1) PL194020B1 (cg-RX-API-DMAC7.html)
PT (1) PT1128831E (cg-RX-API-DMAC7.html)
RU (1) RU2230555C9 (cg-RX-API-DMAC7.html)
SI (1) SI1128831T1 (cg-RX-API-DMAC7.html)
SK (1) SK283936B6 (cg-RX-API-DMAC7.html)
SV (1) SV1999000194A (cg-RX-API-DMAC7.html)
TR (1) TR200101310T2 (cg-RX-API-DMAC7.html)
TW (1) TW580388B (cg-RX-API-DMAC7.html)
UA (1) UA72483C2 (cg-RX-API-DMAC7.html)
UY (1) UY25792A1 (cg-RX-API-DMAC7.html)
WO (1) WO2000027398A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA200103141B (cg-RX-API-DMAC7.html)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19937116A1 (de) * 1999-08-06 2001-02-08 Bayer Ag Moxifloxacin Kochsalzformulierung
GB0209265D0 (en) 2002-04-23 2002-06-05 Novartis Ag Organic compounds
DE10337191A1 (de) * 2003-08-13 2005-03-17 Bayer Healthcare Ag Neue Verwendung von Chinolon-Antibiotika
EP1663226A1 (en) * 2003-09-03 2006-06-07 Ranbaxy Laboratories Limited Pharmaceutical compositions of moxifloxacin and processes for their preparation
CN1330306C (zh) * 2004-08-11 2007-08-08 深圳市天一时科技开发有限公司 莫西沙星明胶胶囊剂及其制备方法
WO2006015545A1 (fr) * 2004-08-11 2006-02-16 Shenzhen Tys R & D Co., Ltd. Capsule de gelatine de moxifloxacin et procede pour sa preparation
WO2007033515A1 (fr) * 2005-09-21 2007-03-29 Shenzhen Tys R & D Co., Ltd. Formulation orale contenant de la moxifloxacine et son procédé de préparation
WO2007033522A1 (fr) * 2005-09-21 2007-03-29 Shenzhen Tys R & D Co., Ltd. Formulation de gélule contenant de la moxifloxacine et son procédé de préparation
CN100363001C (zh) * 2005-09-21 2008-01-23 深圳市天一时科技开发有限公司 一种莫西沙星胶囊剂及其制备方法
PL2349220T3 (pl) * 2008-10-09 2012-12-31 Abdi Ibrahim Ilac Sanayi Ve Ticaret Anonim Sirketi Zastosowanie rozpuszczalników organicznych w granulacji na mokro moksyfloksacyny
EP2735307A1 (de) 2008-12-08 2014-05-28 Ratiopharm GmbH Kompaktiertes Moxifloxacin
TR200907227A2 (tr) * 2009-09-18 2011-04-21 Bi̇lgi̇ç Mahmut Çözünürlüğü yüksek stabil mikronize granüller.
CN101890169B (zh) * 2009-11-16 2013-09-11 江苏亚邦强生药业有限公司 莫西沙星口服制剂及其制备方法
WO2011086577A2 (en) * 2010-01-12 2011-07-21 Msn Laboratories Limited Pharmaceutical composition of moxifloxacin and its pharmaceutically acceptable salts
CN102247313A (zh) * 2010-06-11 2011-11-23 北京润德康医药技术有限公司 一种以莫西沙星为活性成分的口服缓释固体制剂
CN102247314A (zh) * 2011-01-12 2011-11-23 北京润德康医药技术有限公司 一种以莫西沙星为活性成分的口服固体制剂
EP2510929A1 (en) * 2011-04-11 2012-10-17 Innocoll Technologies Limited Methods for treating bacterial infection
MX2011004759A (es) 2011-05-04 2012-11-21 Senosiain S A De C V Lab Nuevas formas solidas de antibioticos.
RU2466718C1 (ru) * 2011-10-14 2012-11-20 Закрытое акционерное общество "Брынцалов-А" Фармацевтический препарат моксифлоксацина
WO2013063271A1 (en) * 2011-10-25 2013-05-02 U.S. Phytotherapy, Inc. Artemisinin and berberine compositions and methods of making
EP2770985A4 (en) 2011-10-25 2015-01-21 U S Phytotherapy Inc ARTEMISININE AND BERBERINE COMPOSITIONS AND METHOD FOR THE PRODUCTION THEREOF
US9675582B2 (en) 2011-10-25 2017-06-13 U.S. Phytotherapy, Inc. Alternative ACT with natural botanical active GRAS ingredients for treatment and prevention of the Zika virus
US9358261B2 (en) 2011-10-25 2016-06-07 U.S. Phytotherapy, Inc. Additional artemisinin and berberine compositions and methods of making
WO2013081044A1 (ja) * 2011-11-30 2013-06-06 富山化学工業株式会社 1-シクロプロピル-8-(ジフルオロメトキシ)-7-[(1r)-1-メチル-2,3-ジヒドロ-1h-イソインドール-5-イル]-4-オキソ-1,4-ジヒドロキノリン-3-カルボン酸のメタンスルホン酸塩水和物含有錠剤
BRPI1106900A2 (pt) 2011-12-26 2013-11-05 Ems Sa Composição farmacêutica sólida compreendendo antibótico da familia das quinolonas e processo de sua obtenção
CN102525982A (zh) * 2012-02-21 2012-07-04 天津市汉康医药生物技术有限公司 一种稳定的盐酸莫西沙星药物组合物
CN102600093B (zh) * 2012-04-11 2013-06-05 南京优科生物医药有限公司 一种莫西沙星片剂及其制备方法
FR2992218B1 (fr) 2012-06-22 2015-01-23 Rivopharm Sa Composition pharmaceutique de chlorhydrate de moxifloxacine et procede de preparation
CN103768063B (zh) * 2012-10-19 2016-04-20 深圳信立泰药业股份有限公司 一种盐酸莫西沙星药物组合物及其制备方法
RU2561037C2 (ru) * 2013-02-07 2015-08-20 Открытое акционерное общество "Химико-фармацевтический комбинат "АКРИХИН" (ОАО "АКРИХИН") Антибактериальная фармацевтическая композиция и способ ее получения
WO2015093669A1 (ko) * 2013-12-20 2015-06-25 씨제이헬스케어 주식회사 목시플록사신 수성 제형 및 이의 제조방법
RU2558932C1 (ru) * 2014-05-22 2015-08-10 Открытое Акционерное Общество "Татхимфармпрепараты" Фармацевтическая композиция моксифлоксацина и способ ее приготовления

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0230881A2 (de) * 1986-01-21 1987-08-05 Bayer Ag Pharmazeutische Zubereitungen von Ciprofloxacin
EP0350733A2 (de) * 1988-07-15 1990-01-17 Bayer Ag 7-(1-Pyrrolidinyl)-3-chinolon- und -naphthyridoncarbon-säure-Derivate, Verfahren zu ihrer Herstellung sowie substituierte mono-und bicyclische Pyrrolidinderivate als Zwischenprodukte zu ihrer Herstellung, und sie enthaltende antibakterielle Mittel und Futterzusatzstoffe

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5286754A (en) 1986-01-21 1994-02-15 Bayer Aktiengesellschaft Pharmaceutical formulations of ciprofloxacin
WO1989003681A1 (en) * 1987-10-19 1989-05-05 Pfizer Inc. Substituted tetralins, chromans and related compounds in the treatment of asthma
JPH01175936A (ja) * 1987-12-28 1989-07-12 Kyorin Pharmaceut Co Ltd 6.8−ジフルオロ−1−(2−フルオロエチル)−1,4−ジヒドロ−7−(4−メチル−1−ピペラジニル)−4−オキソ−3−キノリンカルボン酸を有効成分とする錠剤
EP0449445A3 (en) * 1990-03-27 1993-08-25 Pfizer Inc. Preparation of beta-ketoesters useful in preparing quinolone antibiotics
TW209865B (cg-RX-API-DMAC7.html) * 1992-01-10 1993-07-21 Bayer Ag
DE19546249A1 (de) * 1995-12-12 1997-06-19 Bayer Ag Neue Kristallmodifikation des 1-Cyclopropyl-7-([S,S]-2,8-diazabicyclo[4,3,0]non-8-yl)-6-fluor-1,4-dihydro-8-methoxy-4-oxo-3-chinolincarbonsäure Hydrochlorid (CDCH), Verfahren zu dessen Herstellung und diese enthaltende pharmazeutische Zubereitungen
PA8466701A1 (es) * 1998-01-21 2000-09-29 Pfizer Prod Inc Comprimido de mesilato de trovafloxacino

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0230881A2 (de) * 1986-01-21 1987-08-05 Bayer Ag Pharmazeutische Zubereitungen von Ciprofloxacin
EP0350733A2 (de) * 1988-07-15 1990-01-17 Bayer Ag 7-(1-Pyrrolidinyl)-3-chinolon- und -naphthyridoncarbon-säure-Derivate, Verfahren zu ihrer Herstellung sowie substituierte mono-und bicyclische Pyrrolidinderivate als Zwischenprodukte zu ihrer Herstellung, und sie enthaltende antibakterielle Mittel und Futterzusatzstoffe

Also Published As

Publication number Publication date
AU745282B2 (en) 2002-03-21
CU23260B7 (es) 2008-01-24
RU2230555C2 (ru) 2004-06-20
SV1999000194A (es) 2000-10-16
HN1999000183A (es) 1999-11-01
UY25792A1 (es) 2001-08-27
SI1128831T1 (en) 2005-04-30
ATE279193T1 (de) 2004-10-15
PL194020B1 (pl) 2007-04-30
SK283936B6 (sk) 2004-05-04
PT1128831E (pt) 2005-01-31
BR9915208A (pt) 2001-07-31
DE59910858D1 (de) 2004-11-18
AU1267400A (en) 2000-05-29
JP4809978B2 (ja) 2011-11-09
HUP0104762A2 (hu) 2002-05-29
HU229065B1 (en) 2013-07-29
WO2000027398A1 (de) 2000-05-18
UA72483C2 (en) 2005-03-15
EE04418B1 (et) 2005-02-15
IL142642A0 (en) 2002-03-10
BRPI9915208B1 (pt) 2011-11-01
HK1042245B (zh) 2005-03-11
BRPI9915208A (pt) 2001-07-31
HUP0104762A3 (en) 2002-10-28
IL142642A (en) 2006-10-05
SK6102001A3 (en) 2001-12-03
ES2229786T3 (es) 2005-04-16
KR20010089424A (ko) 2001-10-06
NO20012248L (no) 2001-06-06
NO319342B1 (no) 2005-07-18
BRPI9915208B8 (pt) 2021-07-06
HRP20010332B1 (hr) 2011-01-31
KR100650489B1 (ko) 2006-11-28
CA2349161A1 (en) 2000-05-18
CZ20011652A3 (cs) 2001-08-15
US6610327B1 (en) 2003-08-26
RU2230555C9 (ru) 2006-02-27
MY121114A (en) 2005-12-30
HK1042245A1 (en) 2002-08-09
ZA200103141B (en) 2002-05-07
JP2002529415A (ja) 2002-09-10
BG105459A (en) 2001-12-29
NO20012248D0 (no) 2001-05-07
PE20001304A1 (es) 2000-12-30
CN1149993C (zh) 2004-05-19
TR200101310T2 (tr) 2001-10-22
HRP20010332A2 (en) 2002-06-30
MA26757A1 (fr) 2004-12-20
AR021074A1 (es) 2002-06-12
CN1325306A (zh) 2001-12-05
EE200100259A (et) 2002-12-16
PL348112A1 (en) 2002-05-06
NZ511554A (en) 2003-07-25
CO5070571A1 (es) 2001-08-28
DK1128831T3 (da) 2005-01-17
EP1128831A1 (de) 2001-09-05
CZ292069B6 (cs) 2003-07-16
ID29089A (id) 2001-07-26
TW580388B (en) 2004-03-21
CA2349161C (en) 2008-01-29
EP1128831B1 (de) 2004-10-13

Similar Documents

Publication Publication Date Title
KR100650489B1 (ko) 목시플록사신 제약 제제
KR100348842B1 (ko) 염기성물질로안정화된약제학적조성물
AU661075B2 (en) Stabilized Pharmeceutical Compositions of HMG-CoA Reductase Inhibitors
EP1562573B1 (en) Pharmaceutical pellets comprising tamsulosin and a process for making the same
SK282594B6 (sk) Spôsob prípravy tabletkového prípravku
LT5045B (lt) Prolonguoto išsiskyrimo granulės, turinčios stavudino
US5322698A (en) Process for the preparation of a tablet or dragee composition containing a heat-, light- and moisture-sensitive active ingredient having monoclinic crystal structure
SK106094A3 (en) Pharmaceutical agent
IL125403A (en) Pharmaceutical preparations containing silane and stabilized against recombination
EP2117534B1 (en) A pharmaceutical composition with atorvastatin active ingredient
CZ20032828A3 (en) A stable pharmaceutical composition of pravastatin
HU226528B1 (en) Cyclophosphamide coated tablets
WO2017125841A1 (en) Pharmaceutical compositions of teriflunomide
CZ287149B6 (en) Pharmaceutical preparation containing gemfibrozil
WO2006134610A1 (en) Efavirenz pharmaceutical composition having enhanced dissolution profile
JP4824224B2 (ja) 糖衣製剤